Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Predictive Model for Recurrence and Progression Risk After TURBT for Bladder Cancer on Intraoperative Irrigation Fluid Absorption Volume and Perioperative cfDNA Levels

NCT07589413 is registered in ClinicalTrials.gov with Zhiping Wang as lead sponsor.

NCT NCT07589413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07589413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Predictive Model for Recurrence and Progression Risk After TURBT for Bladder Cancer on Intraoperative Irrigation Fluid Absorption Volume and Perioperative cfDNA Levels
Lead sponsor
Zhiping Wang
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2026
Completion date
April 1, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder (urothelial, transitional cell) cancer, bladder cancer recurrence, progression of bladder cancer, transurethral resection of bladder tumor, urothelial carcinoma of the bladder